How We WorkOrder NowSupport Privacy

Intra-day Movers: Momentum Stocks in Focus – GNBT, ELN, VRX, DCTH

on 21/01/2013

NEW YORK, JANUARY 21, 2013 — (Net PR News) — Generex Biotechnology Corporation (OTC:GNBT) revealed that on Thursday, January 31, 2013, the company’s management has planned an investor conference call.

Generex Biotechnology Corporation’s percentage change dropped -0.51% to close at $0.0390 with the total traded volume of 4.44 million shares, as compared to average volume of 3.42 million shares.

Is GNBT A Solid Investment At These Levels? Find Out Exactly Where GNBT Is Headed With This TREND ANALYSIS REPORT

The Company’s lowest price during last trade was $0.04 while its highest price was $0.04 for the day. GNBT’s total market capitalization is $14.51 million along with 372.06 million shares outstanding. Its beta value stands at 1.60 points and its earning per shares remained $-0.03.

Elan Corporation, plc (ADR) (NYSE:ELN) reported the upsurge of 0.60%. After opening at the price of $9.92, its closing price for the day was $10.00.

ELN’s total trading volume for the day was 2.41 million shares, versus its average volume of 3.37 million shares. The Company’s current market capitalization stands at $5.93 billion along with 593.47 million shares.

Elan’s earning per share is $-0.67 while its beta value stands at 0.93 times.

How Should Investors React To ELN Now? Find Out In This TREND ANALYSIS REPORT

If we look at the previous 5 day’s performance of the stock, it remained pessimistic with the loss of -3.29% and, in its last one month’s trade, it dropped-3.01%.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) reported that Laizer D. Kornwasser, has been named as a member of its executive management team. He will look after the responsibilities of Company Group Chairman/ Executive Vice President, its operations in the U.S. Neurology, Canada and several other U.S. tasks. His role will be effective February 1, 2013 .

Valeant Pharmaceuticals Intl Inc percentage change decreased-0.02% to close at $63.77 with the total traded volume of 1.04 million shares, as compared to average volume of 1.56 million shares.

Is VRX A Solid Investment At These Levels? Find Out Exactly Where VRX Is Headed With This TREND ANALYSIS REPORT

Its market capitalization is $19.44 billion and EPS was $0.09. Its beta value stands at 0.81 times. VRX’s shares were trading within the range of $63.37-$63.90, while its opening price was $63.70. If we look at its previous three months trade, it gained more than 12% while in the last 5 days it remained up 0.22%.

Delcath Systems, Inc. (NASDAQ:DCTH) reported the decline of -2.07% and closed at $1.42 with the total traded volume of 1.50 million shares. The stock’s opening price was $1.46. The company has a total of 75.08 million outstanding shares and its total market capitalization is $106.61 million.

The 52-week price range of the stock remained $1.01 – $4.74, while, during last trade, its minimum price was $1.40 and it gained its highest price of $1.48. The Company’s last 5 days shows an uptrend of 1.43%.

Get A Free Report And Detailed Analysis On DCTH CLICK HERE To Read

About Fast Moving Stocks

FastMovingStock.com is engaged in providing valuable ideas and news information on U.S. stocks on a regular basis. FastMovingStock.com provides detailed research guides on small cap and large cap stocks, helping investors in making wise stock market investment decisions through its free e-newsletter to subscribers.

Disclaimer:

The assembled information disseminated by fastmovingstock.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Fast moving stock.com does not expect that investors will buy and sell securities based on information assembled and presented in fastmovingstock.com. PLEASE always do your own due diligence, and consult your financial advisor.

 

Source: Fast Moving Stock Posted Mon, January 21, 2013 16:37 - Permalink